Abstract

Pulmonary arterial hypertension (PAH) can be diagnosed at rest (rPAH) or in response to exercise (EIPAH), however the clinical significance of EIPAH is unclear. rPAH is associated with reduced pulmonary artery capacitance (PAC), an attenuated increase in cardiac output (CO) and a rise in pulmonary vascular resistance (PVC) during exercise. The presence of these abnormalities in subjects with EIPAH may reflect early pulmonary vasculopathy. PURPOSE: To determine whether clinically significant hemodynamic and ventilatory abnormalities exist in patients with EIPAH, despite normal mean pulmonary artery pressure (mPAP) at rest, and their impact on aerobic capacity and health related quality of life (HRQoL). METHODS: 39 symptomatic patients, NYHA class II (n = 27) or III (n = 12), at risk for PAH, underwent a cardiopulmonary exercise test (CPET) with a right heart catheter in situ. 21 healthy controls (C), matched for age, gender and BMI with EIPAH subjects, underwent CPET for comparison of aerobic capacity and ventilatory response. HRQoL (SF-36) was assessed in all subjects. RESULTS: Following CPET, patient subjects were stratified using World Health Organization PAH diagnostic criteria: resting PAH (mPAP ≥ 25 mmHg at rest, n = 7), EIPAH (mPAP ≤25 mmHg at rest, ≥30mmHg on exercise, n = 22) or no evidence of PAH (nonPAH) (n = 10). Compared with nonPAH, both rPAH and EIPAH were associated with lower CO (7.4±0.7, 8.6±0.5 vs 11.0±0.8 L/min, p<0.05, mean±SEM), higher PVC (4.6±0.7, 2.5±0.3 vs 1.4±0.2 Woods units, p<0.05) and lower PAC (1.2±0.3, 1.8±0.1 vs 2.4±0.2 ml/mmHg, p<0.05) at peak exercise. Compared with C, subjects with rPAH and EIPAH had lower peak oxygen consumption (12.8±1.8, 18.0±0.8 vs 25.6±1.7 ml/kg/min, p<0.01), lower end tidal carbon dioxide at anaerobic threshold (AT) (30.3±3.1, 34.0±0.8 vs 39.4±0.6 mmHg, p<0.01) and a higher ventilatory equivalent for carbon dioxide at AT (49.0±5.4, 39.2±1.7 vs 30.9±0.7, p<0.01). rPAH and EIPAH subjects had impaired HRQoL compared with C (p<0.05). CONCLUSIONS: EIPAH is associated with hemodynamic and ventilatory abnormalities typical of rPAH and is suggestive of a clinically important pulmonary vasculopathy linked to reduced exercise capacity and HRQoL.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.